Showing results (1191-1200 of 6,680) with videos related to
Sort By:
Pageof 668
Neurobiology of Disease|December 6, 2021
Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanismsBrian M Schilder, Elisa Navarro, Towfique RajNeurobiology of Disease|December 6, 2021
Identification of cyclin D1 as a major modulator of 3-nitropropionic acid-induced striatal neurodegenerationPaula Dietrich, Shanta Alli, Megan K Mulligan, et al.Neurobiology of Disease|November 6, 2022
Chemotherapy promotes astrocytic response to Aβ deposition, but not Aβ levels, in a mouse model of amyloid and APOEChristi Anne S Ng, Lucas P Biran, Elena Galvano, et al.Neurobiology of Disease|October 14, 2022
CCL2 recruits fetal microchimeric cells and dampens maternal brain damage in post-partum miceMaria Sbeih, Bénédicte Oulès, Mansour Alkobtawi, et al.Neurobiology of Disease|September 17, 2022
Microglial ion channels: Key players in non-cell autonomous neurodegenerationSouvarish SarkarNeurobiology of Disease|October 8, 2022
Comparison of disease progression between brain-predominant Parkinson's disease versus Parkinson's disease with body-involvement phenotypesDong-Woo Ryu, Sang-Won Yoo, Yoon-Sang Oh, et al.Neurobiology of Disease|January 13, 2022
Body-first Parkinson's disease and variant Creutzfeldt-Jakob disease - similar or different?Amanda L Woerman, Gültekin TamgüneyNeurobiology of Disease|January 15, 2022
Sodium channel expression and transcript variation in the developing brain of human, Rhesus monkey, and mouseJacqueline Heighway, Alicia Sedo, Anjali Garg, et al.Neurobiology of Disease|January 15, 2022
APOE4 confers transcriptomic and functional alterations to primary mouse microgliaSaima I Machlovi, Sarah M Neuner, Brittany M Hemmer, et al.Neurobiology of Disease|January 15, 2022
Clinical and imaging evidence of brain-first and body-first Parkinson's diseaseJacob Horsager, Karoline Knudsen, Michael SommerauerPageof 668